You are here:

MS in the media - 10 November 2017

Published on

4 - 10 November 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

The benefits of exercise

A study found although there is some evidence to suggest exercise could improve symptoms and quality of life in people with MS, not enough health professionals are promoting it as a self-management approach

Source: MD Magazine

MS Trust link: Exercise

Mavenclad made available quickly in England

NHS England has negotiated with the manufacturer of Mavenclad (cladribine) so that people eligible for treatment can access the drug "immediately". Mavenclad was approved by NICE on 2 November.

Source: Daily Mail
Source: Hospital Health Care

MS Trust link: Mavenclad (cladribine) available immediately in England for highly active relapsing multiple sclerosis - MS Trust news item

Print this page